Luxembourg City

Luxembourg City has emerged as a premier European hub for life sciences innovation, distinguished by its strategic focus on personalized medicine and digital health.

The ecosystem is anchored by world-class institutions like the Luxembourg Institute of Health (LIH) and the University of Luxembourg, which lead pioneering academic research in oncology, immunology and neurodegenerative diseases.

As a center for healthcare innovation, the city leverages the MeluXina supercomputer to provide unparalleled high-performance computing for AI-driven drug discovery and biomedical data analysis.

The biotechnology sector thrives here, supported by the Integrated Biobank of Luxembourg (IBBL), which offers standardized biobanking services essential for international clinical trials.

Global pharmaceutical players are increasingly attracted to the region’s robust data privacy frameworks and the European Health Data Space (EHDS) initiatives.

Furthermore, the medical device industry benefits from specialized incubators like the House of BioHealth, which fosters the development of in vitro diagnostics and wearable health technologies.

Luxembourg City also excels in translational medicine, bridging the gap between laboratory breakthroughs and patient care through a collaborative "bed-to-bench-to-bed" approach.

With a business-friendly environment and a diverse pool of scientific talent, the capital provides a fertile ground for healthtech startups and established firms looking to scale in the EU.

This integrated ecosystem makes Luxembourg City a vital node in the global life sciences supply chain and a leader in the shift toward preventative healthcare.